Agenus (NASDAQ: AGEN) to pay part of 13% loan interest in stock
Rhea-AI Filing Summary
AGENUS INC (AGEN) amended a key debt facility through its subsidiary Agenus West, LLC by entering into a Second Loan Modification Agreement with Ocean 1181 LLC. The Borrower issued a Third Amended and Restated Promissory Note that keeps the outstanding principal at $24,750,000, extends the maturity date to November 30, 2029, and sets the interest rate at 13.0% per annum through maturity.
Monthly interest will continue to be paid one-half in cash and one-half in Agenus common stock. The Borrower will pay an extension fee of $247,500, also one-half in cash and one-half in common stock. Shares issued to the lender in connection with this modification are expected to rely on exemptions from registration under Section 4(a)(2) of the Securities Act and/or Regulation D.
Positive
- $24,750,000 debt maturity extended to November 30, 2029, providing longer-term financing stability under the amended promissory note.
Negative
- Debt continues at a relatively high 13.0% per annum interest rate, with ongoing interest and a $247,500 extension fee partly paid in stock, adding financing cost and equity issuance.
8-K Event Classification
Key Figures
Key Terms
Second Loan Modification Agreement financial
Third Amended and Restated Promissory Note financial
Section 4(a)(2) regulatory
Regulation D regulatory
FAQ
What debt change did AGEN (Agenus Inc.) announce in this 8-K?
What is the new maturity date of Agenus Inc. (AGEN)'s amended loan?
What interest rate does AGEN pay on the amended promissory note?
How much is the extension fee on Agenus Inc. (AGEN)'s loan modification?
How are monthly interest payments structured on AGEN’s modified loan?
AI-generated analysis. How Rhea-AI works. Not financial advice.